|
End-of-day quote
Shanghai S.E.
2026-08-20
|
5-day change | 1st Jan Change | ||
| 10.27 CNY | -4.11% |
|
-4.47% | -5.00% |
| Market Cap | 5.96B 885M 758M 707M 649M 1.22B 84.72B 1.24B 8.39B 3.27B 42.46B 3.32B 3.25B 141B | P/E 2024 |
20.4x | P/E 2025 | 46.8x |
|---|---|---|---|---|---|
| Enterprise Value | 5.45B 811M 694M 648M 594M 1.12B 77.57B 1.14B 7.68B 2.99B 38.87B 3.04B 2.98B 129B | EV / Sales 2024 |
0.41x | EV / Sales 2025 | 0.56x |
| Free-Float |
24.73% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -4.11% | ||
| 1 week | -4.47% | ||
| Current month | +11.15% | ||
| 1 month | +17.37% | ||
| 3 months | +12.86% | ||
| 6 months | -3.93% | ||
| Current year | -5.00% |
| 1 week | 10.06 |  | 12.79 |
| 1 month | 8.41 | | 12.79 |
| Current year | 7.54 | | 13.16 |
| 1 year | 7.54 | | 18.13 |
| 3 years | 4.96 | | 18.13 |
| 5 years | 4.96 | | 18.13 |
| 10 years | 4.88 | | 18.13 |
| Manager | Title | Age | Since |
|---|---|---|---|
Wei Dong Zhu
CEO | Chief Executive Officer | 57 | 2016-09-25 |
Ping Guan
DFI | Director of Finance/CFO | 54 | 2022-04-06 |
Rui Qu
IRC | Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Wei Dong Zhu
CHM | Chairman | 57 | 2023-12-14 |
Shi Wei Yin
BRD | Director/Board Member | 51 | 2023-12-25 |
Dan Guo
BRD | Director/Board Member | 56 | 2023-12-25 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.11% | -4.47% | +23.29% | +4.80% | 885M | |
| -1.75% | -2.09% | +19.32% | +99.50% | 97.79B | |
| -2.72% | -1.20% | +49.37% | +166.12% | 53.13B | |
| 0.00% | -2.85% | +1.58% | +278.43% | 23.75B | |
| +1.77% | -0.72% | -12.41% | -13.45% | 8.28B | |
| +4.98% | +1.22% | -34.67% | -20.49% | 7.8B | |
| +0.24% | -0.48% | -15.55% | -23.41% | 6.6B | |
| -4.19% | -3.14% | +4.58% | +16.10% | 6.29B | |
| +2.35% | +2.29% | -2.88% | +19.42% | 5.16B | |
| +1.13% | +3.25% | +9.41% | +19.11% | 3.72B | |
| Average | -0.25% | -1.90% | +4.20% | +54.61% | 21.34B | |
| Weighted average by Cap. | -1.30% | -1.58% | +19.42% | +117.24% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 10.05B 1.49B 1.28B 1.19B 1.1B 2.06B 143B 2.1B 14.16B 5.52B 71.64B 5.61B 5.49B 237B | 10.38B 1.54B 1.32B 1.23B 1.13B 2.13B 148B 2.17B 14.62B 5.7B 74B 5.79B 5.67B 245B |
| Net income | 213M 31.71M 27.15M 25.33M 23.24M 43.68M 3.03B 44.53M 300M 117M 1.52B 119M 116M 5.03B | 134M 19.9M 17.04M 15.9M 14.59M 27.41M 1.9B 27.95M 189M 73.51M 954M 74.72M 73.09M 3.16B |
| Net Debt | -200M -29.69M -25.42M -23.72M -21.76M -40.89M -2.84B -41.7M -281M -110M -1.42B -111M -109M -4.71B | -503M -74.79M -64.03M -59.75M -54.82M -103M -7.16B -105M -709M -276M -3.59B -281M -275M -11.87B |
Employees
2,735
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-20 | CN¥10.27 | -4.11% | 48,948,749 |
| 26-08-19 | CN¥10.71 | -10.00% | 38,561,400 |
| 26-08-18 | CN¥11.90 | +3.12% | 74,244,861 |
| 26-08-17 | CN¥11.54 | -2.45% | 62,280,601 |
| 26-08-14 | CN¥11.83 | +10.05% | 50,959,289 |
- Stock Market
- Stocks
- 600829 Stock
Select your edition
All financial news and data tailored to specific country editions
